Result: The acute reject reaction was not found.
结果：两组均无急性排斥反应发生。
Results The acute reject reaction was not found.
结果无急性排斥反应发生。
CONCLUSION: Zenapax used for immunity induction of renal transplantation can prevent and reduce the occurrence of acute reject reaction, it has safety and good tolerance.
结论：赛尼哌用于肾移植的免疫诱导治疗，可以预防和减少急性排斥反应的发生，安全性和耐受性好。
Methods Randomly investigate 41 liver transplantation patients, among them there were 16 patients with reject reaction (including 12 with acute rejection, 4 with chronic rejection).
方法随机观察肝移植患者41例，其中出现排斥反应16例(急性排斥12例，慢性排斥4例)。
Methods Randomly investigate 41 liver transplantation patients, among them there were 16 patients with reject reaction (including 12 with acute rejection, 4 with chronic rejection).
方法随机观察肝移植患者41例，其中出现排斥反应16例(急性排斥12例，慢性排斥4例)。
应用推荐